| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.3 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.29 | 0.4 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.4 |